Dashboard
Manage Tickers

ZYMEZymeworks Inc.

Nasdaq zymeworks.com


$ 8.71 $ -0.44 (-4.81 %)    

Monday, 17-Jun-2024 13:45:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 485.35 $ 5.39 (1.12 %)
DIA $ 388.21 $ 3.15 (0.82 %)
SPY $ 547.18 $ 5.10 (0.94 %)
TLT $ 93.71 $ -0.15 (-0.16 %)
GLD $ 214.14 $ -0.74 (-0.34 %)
$ 9.04
$ 9.15
$ 8.69 x 100
$ 0.00 x 0
$ 8.69 - $ 9.15
$ 6.02 - $ 13.14
591,023
na
569.49M
$ 0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-06-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Market-Moving News for June 17th
06/17/2024 12:40:12

BBY: 4% | UBS Upgrades Best Buy Co to Buy, Raises Price Target to $106 ZYME: 13% | Zymeworks shares are trading higher after t...

zymeworks-shares-are-trading-higher-after-the-fda-cleared-the-companys-investigational-new-drug-application-for-zw171-for-mesothelin-expressing-cancers-with-the-company-expecting-to-initiate-clinical-development-during-2024
Zymeworks shares are trading higher after ...
06/17/2024 11:45:40

fda-clears-zymeworks-investigational-new-drug-application-for-zw171-for-mesothelin-expressing-cancers-the-company-expects-to-initiate-clinical-development-of-zw171-during-2024
FDA Clears Zymeworks' Investigational New ...
06/17/2024 10:03:10

zymeworks-achieves-key-milestone-with-bla-acceptance-for-zanidatamab-in-china-zymeworks-to-receive-up-to-164m-in-milestone-payments
Zymeworks Achieves Key Milestone with BLA ...
06/10/2024 10:02:52

 Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional b...

navigating-6-analyst-ratings-for-zymeworks
Navigating 6 Analyst Ratings For Zymeworks
06/06/2024 12:00:39

hc-wainwright--co-reiterates-neutral-on-zymeworks-maintains-10-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/06/2024 10:17:58

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

zymeworks-stock-a-deep-dive-into-analyst-perspectives-5-ratings
Zymeworks Stock: A Deep Dive Into Analyst ...
05/07/2024 13:00:42

hc-wainwright--co-reiterates-neutral-on-zymeworks-maintains-10-price-target
HC Wainwright & Co. Reiterates Neutral on ...
05/07/2024 10:21:13

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

citigroup-maintains-buy-on-zymeworks-lowers-price-target-to-16
Citigroup Maintains Buy on Zymeworks, Lowe...
05/03/2024 21:57:07

Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and lowers the price target from $17 to $16.

wells-fargo-maintains-overweight-on-zymeworks-lowers-price-target-to-12
Wells Fargo Maintains Overweight on Zymewo...
05/03/2024 18:04:42

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and lowers the price target from $14 t...

zymeworks-q1-2024-gaap-eps-042-misses-029-estimate-sales-10030m-miss-17431m-estimate
Zymeworks Q1 2024 GAAP EPS $(0.42) Misses ...
05/02/2024 20:27:21

Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by ...

zymeworks-presents-new-data-from-multiple-preclinical-development-programs-at-2024-american-association-for-cancer-research-annual-meeting
Zymeworks Presents New Data from Multiple ...
04/08/2024 10:05:55

Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional bi...

wells-fargo-maintains-overweight-on-zymeworks-raises-price-target-to-14
Wells Fargo Maintains Overweight on Zymewo...
03/12/2024 11:17:18

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $12 t...

hc-wainwright--co-maintains-neutral-on-zymeworks-raises-price-target-to-10
HC Wainwright & Co. Maintains Neutral on Z...
03/11/2024 10:41:44

HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Neutral and raises the price target fr...

zymeworks-q4-adj-eps-016-beats-043-estimate
Zymeworks Q4 Adj EPS $(0.16) Beats $(0.43)...
03/06/2024 21:12:13

Zymeworks (NASDAQ:ZYME) reported quarterly Adj losses of $(0.16) per share which beat the analyst consensus estimate of $(0.43)...

earnings-scheduled-for-march-6-2024
Earnings Scheduled For March 6, 2024
03/06/2024 10:00:02

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

zymeworks-to-present-preclinical-data-on-antibody-drug-conjugate-and-multispecific-platforms-at-the-american-association-for-cancer-research-annual-meeting
Zymeworks To Present Preclinical Data On A...
03/05/2024 21:35:03

Five abstracts accepted for poster presentation highlight company's differentiated antibody-drug conjugate and multispecifi...

a-look-into-healthcare-sector-value-stocks
A Look Into Healthcare Sector Value Stocks
01/22/2024 14:44:12

overview-of-value-stocks-in-the-healthcare-sector
Overview Of Value Stocks In The Healthcare...
01/15/2024 14:42:57

zymeworks-says-cash-cash-equivalents-and-marketable-securities-as-of-december-31-2023-of-approximately-455m-is-expected-to-fund-operations-into-the-second-half-of-2027
Zymeworks Says Cash, Cash Equivalents, And...
01/04/2024 11:17:26

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)